(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 5.08%234.26B | 5.51%143.04B | 7.39%87.3B | 5.65%32.38B | -1.24%222.94B | -6.16%135.56B | -14.84%81.3B | -26.25%30.65B | -0.85%225.73B | -0.90%144.46B |
Operating income | 5.08%234.26B | 5.51%143.04B | 7.39%87.3B | 5.65%32.38B | -1.24%222.94B | -6.16%135.56B | -14.84%81.3B | -26.25%30.65B | -0.85%225.73B | -0.90%144.46B |
Operating expenses | -3.69%-182.1B | -3.86%-111.82B | -6.06%-68.87B | -4.45%-25.41B | 2.05%-175.63B | 5.45%-107.67B | 13.87%-64.93B | 25.66%-24.33B | -1.33%-179.3B | -0.09%-113.87B |
Gross profit | 10.25%52.16B | 11.90%31.22B | 12.64%18.43B | 10.27%6.96B | 1.91%47.31B | -8.81%27.9B | -18.48%16.36B | -28.41%6.32B | -8.43%46.43B | -4.43%30.59B |
Selling expenses | -18.91%-9.18B | -27.23%-5.44B | -38.88%-3.53B | -15.98%-1.29B | -6.33%-7.72B | 18.16%-4.28B | 22.24%-2.54B | 25.10%-1.11B | 16.34%-7.26B | -6.20%-5.23B |
Administrative expenses | -4.16%-13.96B | -8.10%-9.11B | -6.15%-5.56B | -0.22%-2.58B | 0.59%-13.4B | 6.85%-8.43B | 11.88%-5.24B | 8.13%-2.57B | 2.12%-13.48B | -1.67%-9.05B |
Research and development expenses | -9.40%-14.36B | -6.47%-7.98B | -5.85%-4.79B | -10.41%-2.08B | -0.34%-13.13B | 0.85%-7.49B | 11.01%-4.53B | 16.93%-1.88B | 1.98%-13.09B | 1.65%-7.56B |
Profit from asset sales | -83.99%408.46M | -65.05%268.88M | -50.76%270.52M | 738.31%13.77M | 150.99%2.55B | 24.28%769.25M | 9.23%549.36M | -84.47%1.64M | -14.82%1.02B | -5.95%618.95M |
Revaluation surplus | -19.96%392.04M | -30.83%301.21M | -15.81%232.57M | 3.24%122.82M | 58.04%489.77M | 290.89%435.48M | 261.07%276.24M | 1,390.58%118.96M | 301.85%309.91M | 80.42%111.41M |
-Changes in the fair value of other assets | -19.96%392.04M | -30.83%301.21M | -15.81%232.57M | 3.24%122.82M | 58.04%489.77M | 290.89%435.48M | 261.07%276.24M | 1,390.58%118.96M | 301.85%309.91M | 80.42%111.41M |
Impairment and provision | -101.71%-1.87B | -0.70%-552.77M | -55.30%-461.63M | 10.51%-34.58M | 0.08%-926.44M | -10.18%-548.92M | 33.59%-297.25M | 71.21%-38.64M | 26.11%-927.16M | 37.67%-498.22M |
-Other impairment is provision | -101.71%-1.87B | -0.70%-552.77M | -55.30%-461.63M | 10.51%-34.58M | 0.08%-926.44M | -10.18%-548.92M | 33.59%-297.25M | 71.21%-38.64M | 26.11%-927.16M | 37.67%-498.22M |
Special items of operating profit | 87.50%3.94B | 27.81%1.42B | 62.30%934.62M | 118.09%516.4M | 10.45%2.1B | -8.40%1.11B | -23.85%575.85M | -0.77%236.78M | -36.48%1.9B | -3.01%1.21B |
Operating profit | 1.13%15.81B | 7.36%9.06B | 7.73%4.86B | 71.27%1.37B | 18.36%15.64B | -7.89%8.44B | -24.57%4.51B | -61.65%797.37M | -18.18%13.21B | -13.59%9.16B |
Financing cost | -38.19%212.3M | -85.35%46.89M | 201.90%377.78M | -157.75%-139.87M | 190.35%343.49M | 162.63%320.13M | 137.82%125.14M | 68.50%-54.27M | 54.15%-380.16M | 35.14%-511.12M |
Special items of earning before tax | 148.09%347.24M | -42.65%183.41M | -52.59%101.08M | -5.49%90.78M | -84.85%139.97M | -29.71%319.78M | -18.09%213.19M | -37.32%96.06M | 37.26%923.76M | 93.73%454.96M |
Earning before tax | 1.57%16.37B | 2.33%9.29B | 10.09%5.34B | 56.89%1.32B | 17.19%16.12B | -0.30%9.08B | -17.94%4.85B | -59.27%839.17M | -13.98%13.75B | -9.40%9.11B |
Tax | -2.03%-1.8B | 4.68%-1.27B | -3.49%-796.68M | 6.22%-271.47M | -32.17%-1.77B | -0.64%-1.33B | 26.61%-769.84M | 29.61%-289.49M | 38.32%-1.34B | 24.04%-1.32B |
After-tax profit from continuing operations | 1.52%14.57B | 3.53%8.02B | 11.34%4.54B | 90.14%1.05B | 15.58%14.35B | -0.46%7.75B | -16.06%4.08B | -66.67%549.68M | -10.17%12.42B | -6.32%7.78B |
Earning after tax | 1.52%14.57B | 3.53%8.02B | 11.34%4.54B | 90.14%1.05B | 15.58%14.35B | -0.46%7.75B | -16.06%4.08B | -66.67%549.68M | -10.17%12.42B | -6.32%7.78B |
Minority profit | 5.90%2.86B | 8.69%1.87B | 14.03%1.08B | 30.27%429.82M | 27.60%2.7B | 30.10%1.72B | 8.91%947.18M | 7.12%329.93M | -15.13%2.11B | -12.73%1.32B |
Profit attributable to shareholders | 0.50%11.71B | 2.06%6.15B | 10.53%3.46B | 180.01%615.33M | 13.11%11.65B | -6.71%6.03B | -21.51%3.13B | -83.61%219.75M | -9.08%10.3B | -4.90%6.46B |
Basic earnings per share | 0.00%0.41 | 0.00%0.21 | 9.09%0.12 | 100.00%0.02 | 13.89%0.41 | -8.70%0.21 | -21.43%0.11 | -80.00%0.01 | -7.69%0.36 | -4.17%0.23 |
Diluted earnings per share | 0.00%0.41 | 0.00%0.21 | 9.09%0.12 | 100.00%0.02 | 13.89%0.41 | -8.70%0.21 | -21.43%0.11 | -80.00%0.01 | -5.26%0.36 | 0.00%0.23 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data